Gensight Biologics (STU:G49N) Preferred Dividends: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:G49N Gensight Biologics SA STU:G49N
7 GF Score
Price €0.10
GF Value €0.04
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Gensight Biologics Preferred Dividends?

Gensight Biologics STU:G49N 7 Preferred Dividends is €0.00 Mil as of Dec. 2025. GuruFocus rates STU:G49N with a GF Score™ of 7/100 and a GF Value™ of €0.04 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Gensight Biologics's preferred dividends for the six months ended in Dec. 2025 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Gensight Biologics  (STU:G49N) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gensight Biologics Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Gensight Biologics's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gensight Biologics Preferred Dividends Chart

Gensight Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gensight Biologics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:G49N
7GF Score
Gensight Biologics SA STU:G49N
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gensight Biologics Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of €0.00 Mil mean?
Gensight Biologics (STU:G49N) has a Preferred Dividends of €0.00 Mil as of Dec. 2025. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Gensight Biologics and its competitors.
Is Gensight Biologics' Preferred Dividends too high?
Gensight Biologics' current Preferred Dividends is €0.00 Mil. Overall, Gensight Biologics has a GF Score™ of 7/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gensight Biologics' Preferred Dividends compare to VRTX and REGN?
Gensight Biologics' Preferred Dividends of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Biotechnology company?
A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Gensight Biologics and its competitors. Gensight Biologics's current Preferred Dividends is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gensight Biologics stock overvalued right now?
Based on GuruFocus' analysis, Gensight Biologics (STU:G49N) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 160% above its estimated fair value. The current Preferred Dividends is €0.00 Mil. Gensight Biologics' overall GF Score™ is 7/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Gensight Biologics (STU:G49N), the current Preferred Dividends is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gensight Biologics (STU:G49N) Overvalued in 2026?

Based on GuruFocus' analysis, Gensight Biologics stock appears to be overvalued. The current stock price of €0.10 is trading 160% above its estimated GF Value™ of €0.04. GuruFocus considers Gensight Biologics to be Significantly Overvalued.

Key valuation signals for STU:G49N:

  • Preferred Dividends: €0.00 Mil
  • GF Value™: €0.04 vs. price of €0.10 (160% above fair value)
  • GF Score™: 7/100 with 8 warning signs

No single metric tells the full story. See the STU:G49N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gensight Biologics Business Description

Address 74, rue du Faubourg Saint-Antoine, Paris, FRA, 75012
Gensight Biologics SA is a clinical-stage biopharma company focused on developing and commercializing gene therapies for retinal neurodegenerative diseases and central nervous system disorders. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics, to help preserve or restore vision in patients suffering from blinding retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.
7GF Score

Get the complete analysis for STU:G49N

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.04
GF Value